Cargando…

Molecular diagnostics and inhibition of cross‐reactive carbohydrate determinants in Hymenoptera venom allergy

BACKGROUND: The composition of venom extracts, cross‐reactive carbohydrate determinants (CCD) and the component‐resolved diagnostics (CRD) are important fields of investigation. IgE‐reactivity to CCD complicates the interpretation of IgE to Hymenoptera venoms, especially in patients with multiple‐po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jovanovic, Dragana, Peric‐Popadic, Aleksandra, Djuric, Vojislav, Stojanovic, Maja, Lekic, Branislav, Milicevic, Ognjen, Bonaci‐Nikolic, Branka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993137/ https://www.ncbi.nlm.nih.gov/pubmed/36973962 http://dx.doi.org/10.1002/clt2.12230

Ejemplares similares

Risk factors in Hymenoptera venom allergy
por: Ruëff, F., et al.
Publicado: (2017)

Component resolved diagnostics for hymenoptera venom allergy
por: Jakob, Thilo, et al.
Publicado: (2017)

Proteomic features characterization of Hymenoptera venom allergy
por: Matuszewska, Eliza, et al.
Publicado: (2019)

Hymenoptera venom allergy: work disability and occupational impact of venom immunotherapy
por: Paolocci, Giulia, et al.
Publicado: (2014)

Benefits and limitations of sting challenge in hymenoptera venom allergy
por: Aßmus, Katharina, et al.
Publicado: (2021)

Current practices in diagnosis of Hymenoptera venom allergy in Poland
por: Cichocka-Jarosz, Ewa, et al.
Publicado: (2021)

Antigen 5 Allergens of Hymenoptera Venoms and Their Role in Diagnosis and Therapy of Venom Allergy
por: Blank, Simon, et al.
Publicado: (2020)

Facing Hymenoptera Venom Allergy: From Natural to Recombinant Allergens
por: Perez-Riverol, Amilcar, et al.
Publicado: (2015)

Diagnosis of Hymenoptera Venom Allergy: State of the Art, Challenges, and Perspectives
por: Matysiak, Joanna, et al.
Publicado: (2022)

Stinging insect identification in children with Hymenoptera venom allergy and their parents
por: Kaszuba, Jagoda, et al.
Publicado: (2023)

Health-related quality of life in Polish adolescents with Hymenoptera venom allergy treated with venom immunotherapy
por: Cichocka-Jarosz, Ewa, et al.
Publicado: (2012)

90 Improving the Diagnosis of Hymenoptera Venom Allergy: Component Resolved Diagnosis
por: Cifuentes, Liliana, et al.
Publicado: (2012)

New Biomarkers of Hymenoptera Venom Allergy in a Group of Inflammation Factors
por: Packi, Kacper, et al.
Publicado: (2021)

Platelet‐activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy?
por: Bilò, Maria Beatrice, et al.
Publicado: (2021)

Diagnostics in Hymenoptera venom allergy: current concepts and developments with special focus on molecular allergy diagnostics
por: Jakob, Thilo, et al.
Publicado: (2017)

PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy
por: Yavuz, Suleyman Tolga, et al.
Publicado: (2014)

Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?
por: Sahiner, Umit Murat, et al.
Publicado: (2019)

Development of children’s hymenoptera venom allergy quality of life scale (CHVAQoLS)
por: Cichocka-Jarosz, Ewa, et al.
Publicado: (2013)

Allergen-specific immunotherapy of Hymenoptera venom allergy – also a matter of diagnosis
por: Schiener, Maximilian, et al.
Publicado: (2017)

Hymenoptera Allergens: From Venom to “Venome”
por: Spillner, Edzard, et al.
Publicado: (2014)

Gene expression analysis in allergology: the prediction of Hymenoptera venom allergy severity and treatment efficacy
por: Niedoszytko, Marek, et al.
Publicado: (2013)

Allergy and sensitization to Hymenoptera venoms in unreferred adults with a high risk of sting exposure
por: Zink, Alexander, et al.
Publicado: (2019)

Precision Medicine in Hymenoptera Venom Allergy: Diagnostics, Biomarkers, and Therapy of Different Endotypes and Phenotypes
por: Blank, Simon, et al.
Publicado: (2020)

Impact of specific immunotherapy and sting challenge on the quality of life in patients with hymenoptera venom allergy
por: Eitel, Tamara, et al.
Publicado: (2021)

Analysis of Hymenoptera venom allergy in own material. Clinical evaluation of reactions following stings, in patients qualified for venom immunotherapy
por: Chciałowski, Andrzej, et al.
Publicado: (2018)

The Honeybee Venom Major Allergen Api m 10 (Icarapin) and Its Role in Diagnostics and Treatment of Hymenoptera Venom Allergy
por: Jakob, Thilo, et al.
Publicado: (2020)

Major Aortic Reconstruction with the Replacement of Supra-Aortic Branches: Successful Surgical Treatment of Takayasu Arteritis Initially Presented as Congestive Heart Failure
por: Stojanovic, Maja, et al.
Publicado: (2021)

First successful case of in vitro fertilization-embryo transfer with venom immunotherapy for hymenoptera sting allergy
por: Sills, Eric Scott, et al.
Publicado: (2004)

Clinical Features and the Diagnostic Value of Component Allergen-Specific IgE in Hymenoptera Venom Allergy
por: Shin, Yoo Seob, et al.
Publicado: (2012)

Development of Parents’ of Children with Hymenoptera Venom Allergy Quality of Life Scale (PoCHVAQoLS)
por: Brzyski, Piotr, et al.
Publicado: (2015)

Hymenoptera venom allergy in outdoor workers: Occupational exposure, clinical features and effects of allergen immunotherapy
por: Toletone, Alessandra, et al.
Publicado: (2016)

Single‐cell profiling reveals novel cellular heterogeneity of monocytes during Hymenoptera venom allergy
por: Chao, Wen‐Cheng, et al.
Publicado: (2022)

Nanobody‐based human antibody formats act as IgE surrogate in hymenoptera venom allergy
por: Aagaard, Josephine Baunvig, et al.
Publicado: (2022)

Autoimmune and immunoserological markers of COVID-19 pneumonia: Can they help in the assessment of disease severity
por: Stjepanovic, Mihailo I., et al.
Publicado: (2022)

Sensitization to Hymenoptera venom in pollen allergic patients: Frequency and involvement of cross-reacting carbohydrate determinants (CCD)
por: Bergmann-Hug, Katrin, et al.
Publicado: (2020)

Sjögren’s Syndrome and Silicosis – a Case Report
por: Plavsic, Aleksandra, et al.
Publicado: (2015)

Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides
por: Bonaci-Nikolic, Branka, et al.
Publicado: (2005)

Development of a model care pathway for the management of Hymenoptera venom allergy: evidence-based key interventions and indicators
por: Bilò, Maria Beatrice, et al.
Publicado: (2020)

Prevalence and characteristics of Hymenoptera venom allergy in urban school children aged 6 to 18 years living in Trabzon
por: ÖZİŞ BABA, Özge, et al.
Publicado: (2021)

Revealing clinically relevant specific IgE sensitization patterns in Hymenoptera venom allergy with dimension reduction and clustering
por: Kaczmarczyk, Robert, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_37bjanndtkn3oqg7bspt3uincd